Sleep and impulsivity in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 19, Issue 11, 2013, Pages 991-994

  Scullin, Michael K ^a   Sollinger, Ann B ^a   Land, Julia ^a   Wood Siverio, Cathy ^a   Zanders, Lavezza ^a   Lee, Raven ^a   Freeman, Alan ^a   Goldstein, Felicia C ^a   Bliwise, Donald L ^a   Factor, Stewart A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Excessive daytime sleepiness; Impulse control disorder; Parkinson's disease; Restless legs syndrome; Sleep

Indexed keywords

ADULT; AGED; AROUSAL; ARTICLE; COGNITION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE SEVERITY; DREAM; FEMALE; HUMAN; IMPULSIVENESS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MINNESOTA IMPULSE DISORDER INTERVIEW; MOTOR PERFORMANCE; NIGHTMARE; NOCTURIA; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; SLEEP DISORDER; SNORING; UNIFIED PARKINSON DISEASE RATING SCALE;

EXCESSIVE DAYTIME SLEEPINESS; IMPULSE CONTROL DISORDER; PARKINSON'S DISEASE; RESTLESS LEGS SYNDROME; SLEEP;

AGED; COHORT STUDIES; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PARKINSON DISEASE; SLEEP; SLEEP DISORDERS;

EID: 84886588591     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.06.018     Document Type: Article

References (31)

1. Martinez-Martin P., Rodriguez-Blazquez C., Kurtis M.M., Chaudhuri K. The impact of, non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 2011, 26:399-406.
2. Uitti R.J., Tanner C.M., Rajput A.H., Goetz C.G., Klawans H.L., Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989, 12:375-383.
3. Molina J.A., Sainz-Artiga M.J., Fraile A., Jimenez-Jimenez F.J., Villanueva C., Orti-Pareja M., et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?. Mov Disord 2000, 15:869-872.
4. Jimenez-Jimenez F.J., Sayed Y., Garcia-Soldevilla M.A., Barcenilla B. Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 2002, 36:1178-1179.
5. Voon V., Fox S.H. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007, 64:1089-1096.
6. Black K.J., Friedman J.H. Repetitive and impulsive behaviors in treated Parkinson disease. Neurology 2006, 67:1118-1119.
7. Driver-Dunckley E., Samanta J., Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003, 61:422-423.
8. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006, 63:969-973.
9. Vitale C., Santangelo G., Trojano L., Verde F., Rocco M., Grossi D., et al. Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease. Mov Disord 2011, 26:830-836.
10. Voon V., Sohr M., Lang A.E., Potenza M.N., Siderowf A.D., Whetteckey J., et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 2011, 69:986-996.
11. Killgore W.D.S., Balkin T.J., Wesensten N.J. Impaired decision-making following 49 hours of sleep deprivation. JSleep Res 2006, 15:7-13.
12. Killgore W.D.S., Kahn-Greene E.T., Lipizzi E.L., Newman R.A., Kamimori G.H., Balkin T.J. Sleep deprivation reduces perceived emotional intelligence and constructive thinking skills. Sleep Med 2008, 9:517-526.
13. Menz M.M., Büchel C., Peters J. Sleep deprivation is associated with attenuated parametric valuation and control signals in the midbrain during value-based decision making. JNeurosci 2012, 32:6937-6946.
14. Yoo S.S., Gujar N., Hu P., Jolesz F.A., Walker M.P. The human emotional brain without sleep - a prefrontal amygdala disconnect. Curr Biol 2007, 17:R877-R878.
15. Paavonen E.J., Räikkönen K., Lahti J., Komsi N., Heinonen K., Pesonen A.K., et al. Short sleep duration and behavioral symptoms of attention-deficit/hyperactivity disorder in healthy 7-to 8-year-old children. Pediatrics 2009, 123:e857-e864.
16. Pourcher E., Rémillard S., Cohen H. Compulsive habits in restless legs syndrome patients under dopaminergic treatment. JNeurol Sci 2010, 290:52-56.
17. Nirenberg M.J., Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006, 21:524-529.
18. Pontone G., Williams J.R., Bassett S.S., Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006, 67:1258-1261.
19. O'Sullivan S.S., Loane C.M., Lawrence A.D., Evans A.H., Piccini P., Lees A.J. Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease. JNeurol Neurosurg Psychiatry 2011, 82:620-622.
20. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010, 42:781-785.
21. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55:181-184.
22. Fahn S., Elton R.L. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 153-164. Macmillan Health Care Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D. Calne, M. Goldstein (Eds.).
23. Folstein M., Folstein S., McHugh P. 'Mini-mental state': a practical method for, grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
24. Christenson G.A., Faber R.J., de Zwaan M., Raymond N.C., Specker S.M., Ekern M.D., et al. Compulsive buying: descriptive characteristics and psychiatric comorbidity. JClin Psychiatry 1994, 55:5-11.
25. Lavigne G.J., Montplaisir J.Y. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994, 17:739-743.
26. Phillips B., Young T., Finn L., Asher K., Hening W.A., Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000, 160:2137-2141.
27. Johns M.W. Anew method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
28. Bliwise D.L., Trotti L.M., Wilson A.G., Greer S.A., Wood-Siverio C., Juncos J.J., et al. Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class. Mov Disord 2012, 27:1118-1124.
29. Gujar N., Yoo S.S., Hu P., Walker M.P. Sleep deprivation amplifies reactivity of brain reward networks, biasing the appraisal of positive emotional experiences. JNeurosci 2011, 31:4466-4474.
30. Factor S.A., McAlarney T., Sanchez-Ramos J.R., Weiner W.J. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990, 5:280-285.
31. Winkelman J.W., Redline S., Baldwin C.M., Resnick H.E., Newman A.B., Gottlieb D.J. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the sleep heart health study. Sleep 2009, 32:772-778.